Early detection and prevention of cancer can save lives, but current tools often fall short because of suboptimal accuracy and limited accessibility. The Fred Hutch Cancer Center aims to change that ...
Tempus AI TEM shares are up on Tuesday as the company announced the acceptance of 31 abstracts for presentation at the ...
Researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) from short-term survivors (<1year) OS Therapies Inc. (NYSE:OSTX) Leveraging the power ...
SEATTLE, April 17, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...
Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease ...
Region-specific biomarkers FGFR4, FLT1, and WNT5A are linked to tumor behavior and therapeutic response in CRC. Comprehensive genomic profiling (CGP) aids in precision medicine by identifying genetic ...
NEW YORK, NY, UNITED STATES, January 16, 2026 /EINPresswire.com/ — OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results